← All organizations
New York Medical College
Academic/HospitalWebsite ↗
Also known as: CHR/ New York Medical College | Mitchell Cairo | New York Medical College | New York Medical College, Division of Oncology | St. Vincents Catholic Medical Centers | St. Vincent's Comprehensive Cancer Center | St. Vincent's Comprehensive Cancer Center - Manhattan | St. Vincent's Comprehensive Cancer Center, New York | St. Vincent's Comprehensive Cancer Center, New York, New York | St. Vincent's East
Highest phase reached
Phase 4
First clinical trial
Apr 1, 1983Last known activity
Dec 1, 2026
Timeline
1860s
- Jan 1, 1860
New York Medical College— Founded
Drugs by trial phase (86 distinct, 68 trials)
Phase 4 (6 own, 0 via acquisition)
Phase 3 (6 own, 0 via acquisition)
Phase 2 (51 own, 0 via acquisition)
Phase 1 (19 own, 0 via acquisition)
Other trials (4 own, 0 via acquisition)
Indications
Studied for
- Acute Chest Syndrome
- Adenoviridae Infections
- Adrenoleukodystrophy
- Anemia
- Anemia, Aplastic
- Anemia, Diamond-Blackfan
- Anemia, Sickle Cell
- beta-Thalassemia
- Brain Diseases
- Brain Ischemia
- Burkitt Lymphoma
- Cardiovascular Diseases
- Communicable Diseases
- Coronary Disease
- Cytomegalovirus Infections
- Disease
- Epstein-Barr Virus Infections
- Fever
- Fucosidosis
- Gaucher Disease
- Headache
- Heart Diseases
- Hematologic Diseases
- Hepatoblastoma
- Histiocytosis
- Hodgkin Disease
- Hot Flashes
- Huntington Disease
- Hyperinsulinism
- Hypoxia
- Hypoxia-Ischemia, Brain
- Immunologic Deficiency Syndromes
- Infarction
- Infections
- Infertility
- Insulin Resistance
- Ischemia
- Kidney Diseases
- Leukemia
- Leukemia, Lymphoid
- Leukemia, Myelogenous, Chronic, BCR-ABL Positive
- Leukemia, Myeloid
- Leukemia, Myeloid, Acute
- Leukemia, Myelomonocytic, Juvenile
- Leukodystrophy, Globoid Cell
- Leukodystrophy, Metachromatic
- Lupus Erythematosus, Systemic
- Lymphoma
- Lymphoma, B-Cell
- Lymphoma, Large B-Cell, Diffuse
- Lymphoma, Mantle-Cell
- Lymphoma, T-Cell, Peripheral
- Lymphoproliferative Disorders
- Metabolism, Inborn Errors
- Migraine Disorders
- Mucopolysaccharidoses
- Mucopolysaccharidosis I
- Mucopolysaccharidosis VI
- Multiple Myeloma
- Myelodysplastic Syndromes
- Myocardial Infarction
- Myocardial Ischemia
- Neoplasms
- Neoplasms, Plasma Cell
- Neuroblastoma
- Neuronal Ceroid-Lipofuscinoses
- Neutropenia
- Niemann-Pick Diseases
- Niemann-Pick Disease, Type A
- Niemann-Pick Disease, Type C
- Orthostatic Intolerance
- Pancreatic Neoplasms
- Pancytopenia
- Pick Disease of the Brain
- Postural Orthostatic Tachycardia Syndrome
- Precursor Cell Lymphoblastic Leukemia-Lymphoma
- Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
- Preleukemia
- Premature Birth
- Purpura
- Purpura, Thrombocytopenic
- Purpura, Thrombocytopenic, Idiopathic
- Rhabdomyosarcoma
- Sarcoma
- Sarcoma, Ewing
- Sarcopenia
- Scleroderma, Diffuse
- Scleroderma, Systemic
- Sclerosis
- Stress Disorders, Post-Traumatic
- Stress Disorders, Traumatic
- Stress Disorders, Traumatic, Acute
- Syncope
- Syncope, Vasovagal
- Syndrome
- Tachycardia
- Thalassemia
- Thrombocytopenia
- Thromboembolism
- Venous Thromboembolism
Recent trials (50)
- NCT07225972Lead sponsorPhase 3Dec 1, 2026
- NCT07225972OfficialPhase 3Dec 1, 2026
- NCT07013565OfficialPhase 2Aug 7, 2025
- NCT07013565Lead sponsorPhase 2Aug 7, 2025
- NCT06617286Lead sponsorPhase 1/Phase 2Dec 1, 2024
- NCT05987124Lead sponsorPhase 2Dec 1, 2023
- NCT05987124Overall official - principal investigatorPhase 2Dec 1, 2023
- NCT05564598Overall official - principal investigatorPhase 2Jul 1, 2023
- NCT05564598Lead sponsorPhase 2Jul 1, 2023
- NCT05564598Reponsible party - principal investigatorPhase 2Jul 1, 2023
- NCT05253495Sponsor investigatorPhase 2Feb 1, 2022
- NCT05253495Reponsible party - principal investigatorPhase 2Feb 1, 2022
- NCT05253495Lead sponsorPhase 2Feb 1, 2022
- NCT04972942Study chairPhase 2Sep 30, 2021
- NCT04972942Lead sponsorPhase 2Sep 30, 2021
Details
- Founded
- Valhalla, NY, US Jan 1, 1860
- Last known activity
- Dec 1, 2026